Valeo Financial Advisors, LLC Chemo Centryx, Inc. Transaction History

Valeo Financial Advisors, LLC

  • $3.81 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 07, 2022
SELL
$18.38 - $40.5 $183,800 - $405,000
-10,000 Closed
0 $0
Q2 2021

Jul 22, 2021
BUY
$9.59 - $50.88 $95,900 - $508,800
10,000 New
10,000 $134,000
Q1 2021

Apr 12, 2021
SELL
$49.53 - $68.4 $29,718 - $41,040
-600 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$47.25 - $65.16 $28,350 - $39,096
600 New
600 $37,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email